0.00
0.00%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Nutra Pharma
From its filings with the US Securities and Exchange Commission
Nutra Pharma is based in Boca Raton, Florida and is incorporated in California. Its shares trade on OTC under the ticker NPHC. The SEC classifies its business as medicinal chemicals & botanical products. In the fiscal year to 31 December 2025, it reported revenue of $257,612 and a net loss of $2.0m. At that date it held total assets of $584,558 and shareholders' equity of −$16.8m.
Pharma is a biopharmaceutical company with intellectual property for drugs that treat autoimmune disorders, viral diseases and pain.
Nutra Pharma was incorporated under the laws of the state of California on February 1, 2000, under the original name of Exotic-Bird.com.
Since European rules for homeopathic drugs are different than the rules in the US, we cannot estimate when this process will be completed.
June of 2013, we announced the launch of our new homeopathic formula for the treatment of chronic pain in companion animals, Pet Pain–Away.
May of 2016, we signed a license agreement to begin the process of creating an infomercial (Direct Response) campaign for Pet Pain–Away.
In 2023, we moved to our new facility in Boca Raton and have certified our lab for production.
Marketing channel. The arrangement is no longer material to the Company’s current operations.
May of 2016, we signed a license agreement to begin the process of creating an infomercial (Direct Response) campaign for Pet Pain-Away.
In November of 2016, we announced the license agreement with DEG Productions for the marketing and distribution of Pet Pain-Away globally.
Quoted from its 10-K, filed 20 May 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Biotechnology
- Listed since
- 9 Oct 2001
- Employees
- 5
- Website
- nutrapharma.com ↗
- Head office
- 6400 PARK OF COMMERCE BLVD, BOCA RATON, FL, 33487
- Incorporated in
- CA
- Classification
- Medicinal Chemicals & Botanical Products
- Filer status
- Non-accelerated filer<br>Smaller reporting company
Leadership
Pay as last reported
- Dr. Michael FlaxChairman of the Board, Chief Executive Officer, Chief Financial Officer, since 2001
- Dr. Dale VanderputtenChief Scientific Officer$144,000
- Dr. Stewart LonkyDirector
- Mr. Garry PottruckDirector
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Nutra Pharma Corp possesses a unique product offering in the healthcare industry. Their innovative products distinguish them from competitors and provide a competitive advantage.
- The company has a strong focus on research and development, allowing them to continuously introduce new and improved products to the market. This helps maintain their position as pioneers in the industry.
- Nutra Pharma Corp has built a solid brand reputation over the years. They are known for their quality products and have earned the trust of customers, healthcare professionals, and investors.
Weaknesses
- Despite their unique product offering, Nutra Pharma Corp has a limited presence in the market. They face challenges in expanding their reach and increasing market share.
- The company heavily relies on a few key products, which makes them vulnerable to changes in market demand or the introduction of competing products. Diversification is crucial for long-term sustainability.
- Operating in the healthcare industry means Nutra Pharma Corp is subject to stringent regulations. Compliance with regulatory requirements can be time-consuming and costly, affecting the company's operations and profitability.
Opportunities
- As consumers increasingly seek natural and holistic remedies, Nutra Pharma Corp can leverage this trend by expanding their product portfolio to cater to the growing demand.
- The company has the opportunity to venture into international markets, tapping into new customer bases and potentially increasing their market share and revenue.
- Forming strategic partnerships with healthcare organizations or industry players opens doors to new distribution channels, enhances brand visibility, and provides access to resources for further growth.
Threats
- Nutra Pharma Corp operates in a highly competitive market where several established competitors and new entrants vie for market share. The company needs to continuously innovate and differentiate to stay ahead.
- Economic factors, such as recessions or fluctuations in currency exchange rates, can significantly impact consumer spending and demand for healthcare products, thereby affecting Nutra Pharma Corp's sales and revenue.
- Regulatory frameworks governing the healthcare industry are subject to changes, presenting challenges for compliance and potentially impacting the company's ability to bring new products to market.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.